| CKD (n = 16) | ESRD (n = 100) | Control (n = 100) | P value | |
---|---|---|---|---|---|
Gender | Â | 0.004 | |||
Female | 8 (50%) | 31 (31%) | 54 (54%) | ||
Male | 8 (50%) | 69 (96%) | 46 (46%) | ||
 | Mean ± SD | Mean ± SD | Mean ± SD | ||
Age | 40.88 ± 11.10 | 47.10 ± 16.11 | 37.84 ± 12.73 | < 0.001 | |
HB conc. | 16.04 ± 24.54 | 10.10 ± 1.96 | 12.31 ± 1.26 | 0.002 | |
Creatinine conc. | 3.69 ± 5.16 | 8.08 ± 3.03 | 0.82 ± 0.20 | < 0.001 | |
Bilirubin | 0.47 ± 0.14 | 0.63 ± 0.20 | 0.40 ± 0.13 | < 0.001 | |
SGPT | 30.0 ± 4.40 | 27.06 ± 21.85 | 21.06 ± 8.61 | 0.012 | |
SGOT | 38.63 ± 3.70 | 30.40 ± 21.19 | 29.38 ± 9.01 | 0.094 | |
Ca | – | 9.18 ± 0.80 | 8.27 ± 1.14 | < 0.001 | |
P | – | 3.34 ± 0.58 | 5.98 ± 2.40 | < 0.001 | |
PTH | – | 31.30 ± 11.3 | 477.54 ± 439.73 | < 0.001 | |
HBs Ag | Negative | 16 (100.0%) | 100 (100.0%) | 0 (0.0%) | NA |
HCV | Negative | 16 (100%) | 74 (74%) | 100(100%) | < 0.001 |
 | Positive | 0 (0%) | 26 (26%) | 0 (0%) | |
FBS | 106.56 ± 43.58 | 125.5 ± 67.59 |  | 0.279 | |
Urea | 107.75 ± 30.36 |  |  |  | |
GFR | 28.75 ± 13.91 |  |  |  |